OpenLegislation

Chapter VI MODALITIES OF VERIFICATION OF THE SAFETY FEATURES AND DECOMMISSIONING OF THE UNIQUE IDENTIFIER BY PERSONS AUTHORISED OR ENTITLED TO SUPPLY MEDICINAL PRODUCTS TO THE PUBLICF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 25Obligations of persons authorised or entitled to supply medicinal products to the public
  2. 26Derogations from Article 25
  3. 27Obligations when applying the derogations
  4. 28Obligations when supplying only part of a pack
  5. 29Obligations in case of inability to verify the authenticity and decommission the unique identifier
  6. 30Actions to be taken by persons authorised or entitled to supply medicinal products to the public in case of suspected falsification

Annotations

Textual amendments

F1

Regulation revoked (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(hh) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)